Cargando…

Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors

Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Josephine, Yuen, Alexander, Rhoades, Joshua, Barnes, Darina, Zakowski, Phillip, Megna, Dominick J., Catarino, Pedro, Zaffiri, Lorenzo, Rampolla, Reinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794393/
https://www.ncbi.nlm.nih.gov/pubmed/36624019
http://dx.doi.org/10.1016/j.healun.2022.12.016
_version_ 1784860025291800576
author Hwang, Josephine
Yuen, Alexander
Rhoades, Joshua
Barnes, Darina
Zakowski, Phillip
Megna, Dominick J.
Catarino, Pedro
Zaffiri, Lorenzo
Rampolla, Reinaldo
author_facet Hwang, Josephine
Yuen, Alexander
Rhoades, Joshua
Barnes, Darina
Zakowski, Phillip
Megna, Dominick J.
Catarino, Pedro
Zaffiri, Lorenzo
Rampolla, Reinaldo
author_sort Hwang, Josephine
collection PubMed
description Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing.
format Online
Article
Text
id pubmed-9794393
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society for Heart and Lung Transplantation.
record_format MEDLINE/PubMed
spelling pubmed-97943932022-12-28 Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors Hwang, Josephine Yuen, Alexander Rhoades, Joshua Barnes, Darina Zakowski, Phillip Megna, Dominick J. Catarino, Pedro Zaffiri, Lorenzo Rampolla, Reinaldo J Heart Lung Transplant Brief Communication Shortage of organ donors is an ongoing limiting factor in lung transplantation (LT). Despite increasing prevalence of asymptomatic COVID-19 infection, positive COVID-19 testing from a potential donor remains a contraindication at many LT centers. In this report, we present the outcomes of LT utilizing an algorithm based on donor clinical presentation, and COVID-19 real-time reverse transcription polymerase chain reaction (RT-PCR) with cycle threshold (Ct) values evaluation. The Ct value threshold for organ acceptance was >35. A total of 8 COVID-positive donors were included. No donor-to-recipient transmissions of COVID-19 were observed. Short-term outcomes were comparable to those reported in pre-COVID literature. Survival-to-date is 100% with median POD of 161 days. Our findings support the safety and efficacy of utilizing our algorithm including Ct value threshold for selection of donors with incidental COVID-19 positive testing. International Society for Heart and Lung Transplantation. 2023-03 2022-12-28 /pmc/articles/PMC9794393/ /pubmed/36624019 http://dx.doi.org/10.1016/j.healun.2022.12.016 Text en © 2022 International Society for Heart and Lung Transplantation. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Hwang, Josephine
Yuen, Alexander
Rhoades, Joshua
Barnes, Darina
Zakowski, Phillip
Megna, Dominick J.
Catarino, Pedro
Zaffiri, Lorenzo
Rampolla, Reinaldo
Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title_full Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title_fullStr Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title_full_unstemmed Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title_short Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors
title_sort real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental covid-19 positive lung donors
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794393/
https://www.ncbi.nlm.nih.gov/pubmed/36624019
http://dx.doi.org/10.1016/j.healun.2022.12.016
work_keys_str_mv AT hwangjosephine realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT yuenalexander realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT rhoadesjoshua realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT barnesdarina realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT zakowskiphillip realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT megnadominickj realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT catarinopedro realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT zaffirilorenzo realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors
AT rampollareinaldo realtimetranscriptionpolymerasechainreactioncyclethresholdvaluesascriteriaforutilizationofincidentalcovid19positivelungdonors